BioSpace News Archive

Nufactor, Inc., a specialty pharmacy and subsidiary of FFF Enterprises Inc., announced that it has partnered with Verrica Pharmaceuticals to be the exclusive specialty pharmacy to dispense YCANTH™, the first FDA approved treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older.

JanOne (Nasdaq: JAN), the visionary biotech company dedicated to discovering non-addictive treatments for pain, as well as causes of pain, has earned a US patent for its innovative formulation of low-dose naltrexone, Jan123, for treating pain.

Biocom California, the association representing the life science industry of California, issued the following statement regarding the official release of the first ten drugs subject to price controls under the Inflation Reduction Act.

Kiora Pharmaceuticals (NASDAQ: KPRX) invites you to participate in a webinar highlighting the progress of molecular photoswitches in retinitis pigmentosa and the future

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it incorporated Hemostemix Quebec Inc. and has applied for grant funding of $6 Million, to locate production of ACP-01 in Montreal.

Spark Biomedical, Inc. was awarded a $1.15M Phase II grant to develop a Transcutaneous Auricular Neurostimulation device, Sparrow® Hawk, to address the adverse effects of acute stress reaction.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Namida Lab, Inc. has been accepted to the American Cancer Society National Breast Cancer Roundtable.

A new survey from the Association for Diagnostics & Laboratory Medicine found that clinical labs’ robust, rapid response to the COVID-19 pandemic helped to contain the virus and save lives.

Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial Officer, effective August 28, 2023.